세계의 자가면역질환 진단 시장 보고서(2025년)

Autoimmune diseases are characterized by the body's production of antibodies that target and attack its own healthy cells, leading to their destruction. Conditions falling under this category include Crohn's disease, rheumatoid arthritis, Hashimoto's disease, multiple sclerosis, Grave's disease, psoriasis, coeliac disease, type 1 diabetes, lupus, and inflammatory bowel syndrome. The diagnosis of these diseases typically involves immunological tests.

The primary types of tests used for autoimmune disease diagnosis include routine laboratory tests, autoantibody tests, immunologic tests, and other specialized tests. Autoantibody tests play a crucial role in aiding the diagnosis of autoimmune diseases. Various products, such as consumables and assay kits, as well as instruments, are employed in these diagnostic processes. These diagnostic tools find application in diverse sectors, including clinical laboratories, hospitals, and other relevant healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The autoimmune disease diagnosis market research report is one of a series of new reports from The Business Research Company that provides autoimmune disease diagnosis market statistics, including autoimmune disease diagnosis industry global market size, regional shares, competitors with a autoimmune disease diagnosis market share, detailed autoimmune disease diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the autoimmune disease diagnosis industry. This autoimmune disease diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The autoimmune disease diagnosis market size has grown strongly in recent years. It will grow from $5.84 billion in 2024 to $6.2 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to the rising incidence of autoimmune diseases, emerging markets growth, increased healthcare expenditure, and high prevalence in women.

The autoimmune disease diagnosis market size is expected to see strong growth in the next few years. It will grow to $8.65 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increased funding for autoimmune (AI) diagnostics, faster economic growth, growing awareness about autoimmune diseases, and biomarker discovery. Major trends in the forecast period include partnering with other players, investing in artificial intelligence companies, collaborating with the government, and developing at-home rapid test kits.

The forecast of 8.7% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. rheumatology diagnostics by inflating prices of multiplex autoantibody testing platforms and flow cytometry reagents developed in Switzerland and Belgium, resulting in delayed diagnoses and higher immunology lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

A surge in the prevalence of autoimmune diseases has significantly contributed to the expansion of the autoimmune disease diagnosis market. Notably, in February 2023, Multiple Sclerosis Australia reported a substantial increase in Multiple Sclerosis (MS) cases in Australia, with a recorded count of 33,335 patients in 2021. This figure reflects a notable surge of 30% (7,728 individuals) over the previous four years, from 25,607 in the preceding period. The escalating incidence of autoimmune disorders globally stands as a driving force behind the heightened demand and growth witnessed within the autoimmune disease diagnosis market.

The anticipated growth of the autoimmune disease diagnosis market is closely intertwined with the escalating healthcare expenditures observed in recent years. Healthcare expenditure, quantifying the total resources allocated to healthcare-related products and services, serves as a fundamental metric indicating population health and healthcare system efficacy. Heightened healthcare spending translates to expedited access to healthcare services, consequently leading to enhanced identification, treatment, and outcomes for individuals afflicted by autoimmune conditions. Notably, as of September 2023, the Centers for Medicare & Medicaid Services in the United States disclosed a 2.7 percent increase in national health spending, reaching a staggering $4.3 trillion in 2021, averaging $12,914 per individual and representing 18.3% of the Gross Domestic Product (GDP). This upward trajectory in healthcare expenditure remains a pivotal catalyst propelling advancements within the autoimmune disease diagnosis market.

Biosensors and nano biosensors stand as groundbreaking tools within the autoimmune disease diagnosis market, offering rapid and efficient antibody detection. These cutting-edge technologies are favored for their cost-effectiveness, exceptional sensitivity, user-friendly nature, multiplexing capabilities, and swift diagnostic outcomes. Beyond merely measuring antibody quantities in human blood serum with remarkable sensitivity, they also gauge antibody activity utilizing portable optical label-free biosensors grounded in spectral correlation interferometry. This point-of-care technology delivers a more integrated, informative, timely, and precise diagnosis of autoimmune diseases compared to traditional methods, enhancing the diagnostic landscape significantly.

Leading entities operating in the autoimmune disease diagnosis market are directing their efforts toward pioneering solutions such as the Phadia 2500+ series autoimmune testing instruments, aiming to better cater to the demands of their clientele. These antibody instruments are instrumental in conducting laboratory tests designed to identify autoimmune disorders. Particularly noteworthy, in May 2022, Thermo Fisher Scientific Inc., a prominent US-based company specializing in life sciences solutions, specialized diagnostics, laboratory services, and biotechnology, introduced the innovative Phadia 2500+ range of equipment. This advanced series of instruments offers expanded capabilities, facilitating integration and further automation for EliA autoimmune diagnostics. Its enhanced functionalities assist in diagnosing various autoimmune diseases, including but not limited to celiac disease, connective tissue disease (CTD), antiphospholipid syndrome (APS), rheumatoid arthritis, autoimmune thyroid disease, and autoimmune liver disease, catering to the diverse spectrum of autoimmune conditions.

Major companies operating in the autoimmune disease diagnosis market include Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc., bioMerieux SA, SQI Diagnostics, SCHILLER Healthcare India Pvt. Ltd, Covidien Healthcare India Private Limited, Philips Healthcare India, Fisher & Paykel Healthcare India Private Limited, Smith's Medical India Pvt Ltd, Agappe Diagnostics Ltd, Accord Medical Products Private Limited, Lepu Medical Technology Company (Beijing) Co., Ltd, Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, GE Healthcare China Co., Ltd, Roche Holding AG, Koninklijke Philips, Theradiag, Sanofi, Themis Bioscience, Becton Dickinson and Company

North America was the largest region in the autoimmune disease diagnosis market in 2024. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the autoimmune disease diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The autoimmune disease diagnosis market includes revenue earned by diagnostic assay kits, reagents, consumables, and instruments used for the diagnosis of autoimmune diseases. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Autoimmune Disease Diagnosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autoimmune disease diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autoimmune disease diagnosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The autoimmune disease diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Consumables And Assay Kits, Instruments
• 2) By End User: Clinical Laboratories, Hospitals, Others
• 3) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests
• Subsegments:
• 1) By Consumables And Assay Kits: ELISA Kits; Reagents And Test Kits; Sample Collection And Preservation Devices; Control And Calibration Materials
• 2) By Instruments: Immunoassay Analyzers; Flow Cytometers; Luminometers; Microscopes; Other Diagnostic Devices
• Companies Mentioned: Siemens Healthineers AG; Abbott Laboratories; Thermo Fisher Scientific Inc; Bio-Rad Laboratories Inc; F. Hoffmann-La Roche Ltd; Danaher Corporation; AESKU Diagnostics GmbH & Co. KG; Trinity Biotech plc.; bioMerieux SA; SQI Diagnostics; SCHILLER Healthcare India Pvt. Ltd; Covidien Healthcare India Private Limited; Philips Healthcare India; Fisher & Paykel Healthcare India Private Limited; Smith's Medical India Pvt Ltd; Agappe Diagnostics Ltd; Accord Medical Products Private Limited; Lepu Medical Technology Company (Beijing) Co., Ltd; Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co., Ltd; Shanghai Runda Medical Technology Co., Ltd; GE Healthcare China Co., Ltd; Roche Holding AG; Koninklijke Philips; Theradiag; Sanofi; Themis Bioscience; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Autoimmune Disease Diagnosis Market Characteristics

3. Autoimmune Disease Diagnosis Market Trends And Strategies

4. Autoimmune Disease Diagnosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Autoimmune Disease Diagnosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Autoimmune Disease Diagnosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Autoimmune Disease Diagnosis Market Growth Rate Analysis
• 5.4. Global Autoimmune Disease Diagnosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Autoimmune Disease Diagnosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Autoimmune Disease Diagnosis Total Addressable Market (TAM)

6. Autoimmune Disease Diagnosis Market Segmentation

• 6.1. Global Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables And Assay Kits
• Instruments
• 6.2. Global Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Routine Laboratory Tests
• Autoantibodies Tests
• Immunologic Tests
• Other Tests
• 6.3. Global Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Laboratories
• Hospitals
• Other End Users
• 6.4. Global Autoimmune Disease Diagnosis Market, Sub-Segmentation Of Consumables And Assay Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ELISA Kits
• Reagents And Test Kits
• Sample Collection And Preservation Devices
• Control And Calibration Materials
• 6.5. Global Autoimmune Disease Diagnosis Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunoassay Analyzers
• Flow Cytometers
• Luminometers
• Microscopes
• Other Diagnostic Devices

7. Autoimmune Disease Diagnosis Market Regional And Country Analysis

• 7.1. Global Autoimmune Disease Diagnosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Autoimmune Disease Diagnosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Autoimmune Disease Diagnosis Market

• 8.1. Asia-Pacific Autoimmune Disease Diagnosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Autoimmune Disease Diagnosis Market

• 9.1. China Autoimmune Disease Diagnosis Market Overview
• 9.2. China Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Autoimmune Disease Diagnosis Market

• 10.1. India Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Autoimmune Disease Diagnosis Market

• 11.1. Japan Autoimmune Disease Diagnosis Market Overview
• 11.2. Japan Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Autoimmune Disease Diagnosis Market

• 12.1. Australia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Autoimmune Disease Diagnosis Market

• 13.1. Indonesia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Autoimmune Disease Diagnosis Market

• 14.1. South Korea Autoimmune Disease Diagnosis Market Overview
• 14.2. South Korea Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Autoimmune Disease Diagnosis Market

• 15.1. Western Europe Autoimmune Disease Diagnosis Market Overview
• 15.2. Western Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Autoimmune Disease Diagnosis Market

• 16.1. UK Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Autoimmune Disease Diagnosis Market

• 17.1. Germany Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Autoimmune Disease Diagnosis Market

• 18.1. France Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Autoimmune Disease Diagnosis Market

• 19.1. Italy Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Autoimmune Disease Diagnosis Market

• 20.1. Spain Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Autoimmune Disease Diagnosis Market

• 21.1. Eastern Europe Autoimmune Disease Diagnosis Market Overview
• 21.2. Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Autoimmune Disease Diagnosis Market

• 22.1. Russia Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Autoimmune Disease Diagnosis Market

• 23.1. North America Autoimmune Disease Diagnosis Market Overview
• 23.2. North America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Autoimmune Disease Diagnosis Market

• 24.1. USA Autoimmune Disease Diagnosis Market Overview
• 24.2. USA Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Autoimmune Disease Diagnosis Market

• 25.1. Canada Autoimmune Disease Diagnosis Market Overview
• 25.2. Canada Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Autoimmune Disease Diagnosis Market

• 26.1. South America Autoimmune Disease Diagnosis Market Overview
• 26.2. South America Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Autoimmune Disease Diagnosis Market

• 27.1. Brazil Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Autoimmune Disease Diagnosis Market

• 28.1. Middle East Autoimmune Disease Diagnosis Market Overview
• 28.2. Middle East Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Autoimmune Disease Diagnosis Market

• 29.1. Africa Autoimmune Disease Diagnosis Market Overview
• 29.2. Africa Autoimmune Disease Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Autoimmune Disease Diagnosis Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Autoimmune Disease Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Autoimmune Disease Diagnosis Market Competitive Landscape And Company Profiles

• 30.1. Autoimmune Disease Diagnosis Market Competitive Landscape
• 30.2. Autoimmune Disease Diagnosis Market Company Profiles
  • 30.2.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bio-Rad Laboratories Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Autoimmune Disease Diagnosis Market Other Major And Innovative Companies

• 31.1. Danaher Corporation
• 31.2. AESKU Diagnostics GmbH & Co. KG
• 31.3. Trinity Biotech plc.
• 31.4. bioMerieux SA
• 31.5. SQI Diagnostics
• 31.6. SCHILLER Healthcare India Pvt. Ltd
• 31.7. Covidien Healthcare India Private Limited
• 31.8. Philips Healthcare India
• 31.9. Fisher & Paykel Healthcare India Private Limited
• 31.10. Smith's Medical India Pvt Ltd
• 31.11. Agappe Diagnostics Ltd
• 31.12. Accord Medical Products Private Limited
• 31.13. Lepu Medical Technology Company (Beijing) Co., Ltd
• 31.14. Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co., Ltd
• 31.15. Shanghai Runda Medical Technology Co., Ltd

32. Global Autoimmune Disease Diagnosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Autoimmune Disease Diagnosis Market

34. Recent Developments In The Autoimmune Disease Diagnosis Market

35. Autoimmune Disease Diagnosis Market High Potential Countries, Segments and Strategies

• 35.1 Autoimmune Disease Diagnosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Autoimmune Disease Diagnosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Autoimmune Disease Diagnosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer